{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T02:22:03Z","timestamp":1792981323575,"version":"4.5.0"},"reference-count":104,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.jtha.2025.01.009","type":"journal-article","created":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T04:06:17Z","timestamp":1739160377000},"page":"1185-1202","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Basics of diagnosis and treatment of venous thromboembolism"],"prefix":"10.1016","volume":"23","author":[{"given":"Catrin","family":"Cox","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3871-8491","authenticated-orcid":false,"given":"Lara N.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2025.01.009_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.tru.2023.100132","article-title":"VTE epidemiology and challenges for VTE prevention at the population level","volume":"10","author":"Br\u00e6kkan","year":"2023","journal-title":"Thromb Update"},{"key":"10.1016\/j.jtha.2025.01.009_bib2","first-page":"809","article-title":"The global burden of unsafe medical care: analytic modelling of observational studies","volume":"22","author":"Jha","year":"2013","journal-title":"BMJ Qual Saf"},{"key":"10.1016\/j.jtha.2025.01.009_bib3","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-012789","article-title":"Clinical characteristics associated with diagnostic delay of pulmonary embolism in primary care: a retrospective observational study","volume":"7","author":"Hendriksen","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.jtha.2025.01.009_bib4","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0140-6736(20)32658-1","article-title":"Venous thromboembolism","volume":"398","author":"Khan","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2025.01.009_bib5","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/jth.14210","article-title":"Cerebral venous sinus thrombosis","volume":"16","author":"Capecchi","year":"2018","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.01.009_bib6","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S2468-1253(24)00155-9","article-title":"Portal vein thrombosis: diagnosis, management, and endpoints for future clinical studies","volume":"9","author":"Elkrief","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jtha.2025.01.009_bib7","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1056\/NEJMra2207738","article-title":"Primary Budd\u2013Chiari syndrome","volume":"388","author":"Garcia-Pag\u00e1n","year":"2023","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2025.01.009_bib8","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/bjh.18189","article-title":"Addendum to guidelines on the investigation and management of venous thrombosis at unusual sites (Br. J. Haematol. 2012;159:28\u201338): use of direct oral anticoagulants","volume":"198","author":"Riat","year":"2022","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2025.01.009_bib9","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1365-2141.2012.09249.x","article-title":"Guidelines on the investigation and management of venous thrombosis at unusual sites","volume":"159","author":"Tait","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2025.01.009_bib10","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1182\/bloodadvances.2018024802","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy","volume":"2","author":"Bates","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2025.01.009_bib11","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1182\/bloodadvances.2018022954","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients","volume":"2","author":"Sch\u00fcnemann","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2025.01.009_bib12","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1182\/bloodadvances.2019000975","article-title":"American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients","volume":"3","author":"Anderson","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2025.01.009_bib14","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1161\/ATVBAHA.114.304488","article-title":"ISTH Steering Committee for\u00a0World Thrombosis Day. Thrombosis: a major contributor to global disease burden","volume":"34","author":"Raskob","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2025.01.009_bib15","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/archinte.158.6.585","article-title":"Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study","volume":"158","author":"Silverstein","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jtha.2025.01.009_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12722","article-title":"Sex-specific aspects of venous thromboembolism: what is new and what is next?","volume":"6","author":"Scheres","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.01.009_bib17","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1001\/archinte.162.11.1245","article-title":"Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study","volume":"162","author":"Heit","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jtha.2025.01.009_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2022.100030","article-title":"A\u00a0systematic approach to venous thromboembolism prevention: a focus on UK experience","volume":"7","author":"Clapham","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.01.009_bib20","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1001\/jama.279.14.1094","article-title":"Does this patient have deep vein thrombosis?","volume":"279","author":"Anand","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.jtha.2025.01.009_bib21","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jacc.2010.05.071","article-title":"Clinical characteristics, management, and outcomes of patients diagnosed with acute pulmonary embolism in the emergency department: initial report of EMPEROR (Multicenter Emergency Medicine Pulmonary Embolism in the Real World Registry)","volume":"57","author":"Pollack","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jtha.2025.01.009_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12570","article-title":"Menstruation, anticoagulation, and contraception: VTE and uterine bleeding","volume":"5","author":"Samuelson Bannow","year":"2021","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.01.009_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12647","article-title":"Communication at diagnosis of venous thromboembolism: lasting impact of verbal and nonverbal provider communication on patients","volume":"6","author":"Hernandez-Nino","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.01.009_bib24","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/bjh.18239","article-title":"Thrombophilia testing: a British Society for Haematology guideline","volume":"198","author":"Arachchillage","year":"2022","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2025.01.009_bib25","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1056\/NEJMoa1506623","article-title":"Screening for occult cancer in unprovoked venous thromboembolism","volume":"373","author":"Carrier","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2025.01.009_bib26","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1111\/jth.13791","article-title":"Occult cancer screening in patients with venous thromboembolism: guidance from the SSC of the ISTH","volume":"15","author":"Delluc","year":"2017","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.01.009_bib27","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1111\/jth.15776","article-title":"Management of bleeding risk in patients who receive anticoagulant therapy for venous thromboembolism: Communication from the ISTH SSC Subcommittee on Predictive and Diagnostic Variables in Thrombotic Disease","volume":"20","author":"den Exter","year":"2022","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.01.009_bib28","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/S0140-6736(97)08140-3","article-title":"Value of assessment of pre-test probability of deep-vein thrombosis in clinical management","volume":"350","author":"Wells","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2025.01.009_bib29","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1055\/s-0037-1614511","article-title":"Application of a diagnostic clinical model for the management of hospitalised patients with suspected deep vein thrombosis","volume":"81","author":"Wells","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.01.009_bib30","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1056\/NEJMoa023153","article-title":"Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis","volume":"349","author":"Wells","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2025.01.009_bib31","doi-asserted-by":"crossref","first-page":"165","DOI":"10.7326\/0003-4819-144-3-200602070-00004","article-title":"Prediction of pulmonary embolism in the emergency department: the revised Geneva score","volume":"144","author":"Le Gal","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jtha.2025.01.009_bib32","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1001\/archinte.168.19.2131","article-title":"Simplification of the revised Geneva score for assessing clinical probability of pulmonary embolism","volume":"168","author":"Klok","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jtha.2025.01.009_bib33","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0140-6736(17)30885-1","article-title":"Simplified diagnostic management of suspected pulmonary embolism (the YEARS study): a prospective, multicentre, cohort study","volume":"390","author":"van der Hulle","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2025.01.009_bib34","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1111\/j.1538-7836.2004.00790.x","article-title":"Clinical criteria to prevent unnecessary diagnostic testing in emergency department patients with suspected pulmonary embolism","volume":"2","author":"Kline","year":"2004","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.01.009_bib35","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1160\/TH07-05-0321","article-title":"Further validation and simplification of the Wells clinical decision rule in pulmonary embolism","volume":"99","author":"Gibson","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.01.009_bib36","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1182\/bloodadvances.2018024828","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: diagnosis of venous thromboembolism","volume":"2","author":"Lim","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2025.01.009_bib37","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1111\/j.1538-7836.2005.01556.x","article-title":"Management studies using a combination of D-dimer test result and clinical probability to rule out venous thromboembolism: a systematic review","volume":"3","author":"Ten Cate-Hoek","year":"2005","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.01.009_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2024.102335","article-title":"D-dimer diagnostics: can I use any D-dimer assay? Bridging the knowledge-to-action gap","volume":"8","author":"Selby","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.01.009_bib39","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/j.1538-7836.2008.02981.x","article-title":"D-Dimer for venous thromboembolism diagnosis: 20 years later","volume":"6","author":"Righini","year":"2008","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.01.009_bib40","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2021-067378","article-title":"Diagnosis of deep vein thrombosis with D-dimer adjusted to clinical probability: prospective diagnostic management study","volume":"376","author":"Kearon","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.jtha.2025.01.009_bib41","first-page":"3441","article-title":"Age-adjusted and clinical probability adapted d-dimer cutoffs to rule out pulmonary embolism: a narrative review of clinical trials","volume":"13","author":"Righini","year":"2024","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jtha.2025.01.009_bib42","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1111\/jth.13403","article-title":"Current and future perspectives in imaging of venous thromboembolism","volume":"14","author":"Dronkers","year":"2016","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.01.009_bib43","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01647-2019","volume":"54","author":"Konstantinides","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jtha.2025.01.009_bib44","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1093\/eurheartj\/ehz726","article-title":"The 2019 ESC Guidelines on the diagnosis and management of acute pulmonary embolism","volume":"40","author":"Konstantinides","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2025.01.009_bib45","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1164\/rccm.200506-862OC","article-title":"Derivation and validation of a prognostic model for pulmonary embolism","volume":"172","author":"Aujesky","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jtha.2025.01.009_bib46","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1001\/archinternmed.2010.199","article-title":"Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism","volume":"170","author":"Jim\u00e9nez","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jtha.2025.01.009_bib47","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/jth.12146","article-title":"Hestia criteria can safely select patients with pulmonary embolism for outpatient treatment irrespective of right ventricular function","volume":"11","author":"Zondag","year":"2013","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.01.009_bib48","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1093\/eurheartj\/ehab373","article-title":"Triaging acute pulmonary embolism for home treatment by Hestia or simplified PESI criteria: the HOME-PE randomized trial","volume":"42","author":"Roy","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2025.01.009_bib49","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1136\/thoraxjnl-2018-211539","article-title":"British Thoracic Society Guideline for the initial outpatient management of pulmonary embolism (PE)","volume":"73","author":"Howard","year":"2018","journal-title":"Thorax"},{"key":"10.1016\/j.jtha.2025.01.009_bib50","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/rth2.12216","article-title":"Pulmonary embolism response teams: purpose, evidence for efficacy, and future research directions","volume":"3","author":"Rosovsky","year":"2019","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.01.009_bib51","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1182\/bloodadvances.2020001830","article-title":"American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism","volume":"4","author":"Ortel","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2025.01.009_bib52","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/hep.31646","article-title":"Vascular liver disorders, portal vein thrombosis, and procedural bleeding in patients with liver disease: 2020 Practice Guidance by the American Association for the study of liver diseases","volume":"73","author":"Northup","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jtha.2025.01.009_bib53","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1007903","article-title":"Oral rivaroxaban for symptomatic venous thromboembolism","volume":"363","author":"EINSTEIN","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2025.01.009_bib54","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1113572","article-title":"Oral rivaroxaban for the treatment of symptomatic pulmonary embolism","volume":"366","author":"EINSTEIN\u2013PE Investigators","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2025.01.009_bib55","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJMoa1302507","article-title":"Oral apixaban for the treatment of acute venous thromboembolism","volume":"369","author":"Agnelli","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2025.01.009_bib56","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1056\/NEJMoa0906598","article-title":"Dabigatran versus warfarin in the treatment of acute venous thromboembolism","volume":"361","author":"Schulman","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2025.01.009_bib57","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJMoa1306638","article-title":"Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism","volume":"369","author":"Hokusai-VTE","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2025.01.009_bib58","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.thromres.2014.06.020","article-title":"Direct oral anticoagulants in the treatment of acute venous thromboembolism: a systematic review and meta-analysis","volume":"134","author":"G\u00f3mez-Outes","year":"2014","journal-title":"Thromb Res"},{"issue":"Supplement","key":"10.1016\/j.jtha.2025.01.009_bib59","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1378\/chest.08-0658","article-title":"Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"133","author":"Kearon","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.jtha.2025.01.009_bib60","doi-asserted-by":"crossref","first-page":"867","DOI":"10.7326\/0003-4819-140-11-200406010-00007","article-title":"Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial","volume":"140","author":"B\u00fcller","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jtha.2025.01.009_bib61","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa035451","article-title":"Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism","volume":"349","author":"B\u00fcller","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2025.01.009_bib62","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12514","article-title":"Impact of oral anticoagulant choice for the secondary prevention of venous thromboembolism on the risk of inpatient bleeding","volume":"5","author":"MacLehose","year":"2021","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.01.009_bib63","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1177\/1074248415575154","article-title":"Case fatality rates of recurrent thromboembolism and bleeding in patients receiving direct oral anticoagulants for the initial and extended treatment of venous thromboembolism: a systematic review","volume":"20","author":"G\u00f3mez-Outes","year":"2015","journal-title":"J\u00a0Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.jtha.2025.01.009_bib64","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.7326\/M21-1094","article-title":"Long-term risk for major bleeding during extended oral anticoagulant therapy for first unprovoked venous thromboembolism : a systematic review and meta-analysis","volume":"174","author":"Khan","year":"2021","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jtha.2025.01.009_bib65","article-title":"Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis","volume":"366","author":"Khan","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.jtha.2025.01.009_bib66","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/acem.13399","article-title":"Systematic review and meta-analysis of outcomes of patients with subsegmental pulmonary embolism with and without anticoagulation treatment","volume":"25","author":"Bariteau","year":"2018","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.jtha.2025.01.009_bib67","first-page":"29","article-title":"Risk for recurrent venous thromboembolism in patients with subsegmental pulmonary embolism managed without anticoagulation: a Multicenter Prospective Cohort Study","volume":"175","author":"Le","year":"2021","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jtha.2025.01.009_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2024.102432","article-title":"Illustrated state-of-the-art capsules of the ISTH 2024 congress","volume":"8","author":"Ward","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.01.009_bib69","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1055\/s-0040-1710314","article-title":"Treatment of venous thromboembolism in special populations with direct oral anticoagulants","volume":"120","author":"Bavalia","year":"2020","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.01.009_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.102240","article-title":"Use of direct oral anticoagulants for venous thromboembolism treatment at extremes of body weight, renal and liver function: an illustrated review","volume":"7","author":"Speed","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.01.009_bib71","doi-asserted-by":"crossref","first-page":"e884","DOI":"10.1016\/S2352-3026(20)30327-6","article-title":"Safety of direct oral anticoagulant exposure during pregnancy: a retrospective cohort study","volume":"7","author":"Beyer-Westendorf","year":"2020","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jtha.2025.01.009_bib72","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1182\/hematology.2022000401","article-title":"Anticoagulant therapy for women: implications for menstruation, pregnancy, and lactation","volume":"2022","author":"DeLoughery","year":"2022","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jtha.2025.01.009_bib73","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1111\/jth.15358","article-title":"Use of direct oral anticoagulants in patients with obesity for treatment and prevention of venous thromboembolism: updated communication from the ISTH SSC Subcommittee on Control of Anticoagulation","volume":"19","author":"Martin","year":"2021","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.01.009_bib74","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1055\/s-0043-1775982","article-title":"Factor Xa inhibitor plasma concentrations and clinical outcomes in patients weighing <\/=50 kg-experience from four UK centers","volume":"124","author":"Speed","year":"2024","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.01.009_bib75","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1200\/JCO.2000.18.17.3078","article-title":"Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis","volume":"18","author":"Hutten","year":"2000","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtha.2025.01.009_bib76","doi-asserted-by":"crossref","first-page":"3972","DOI":"10.1182\/blood-2014-01-549733","article-title":"Predictors of venous thromboembolism recurrence and bleeding among active cancer patients: a population-based cohort study","volume":"123","author":"Chee","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.01.009_bib77","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13045-022-01289-1","article-title":"Direct oral anticoagulant versus low molecular weight heparin for the treatment of cancer-associated venous thromboembolism: 2022 updated systematic review and meta-analysis of randomized controlled trials","volume":"15","author":"Frere","year":"2022","journal-title":"J\u00a0Hematol Oncol"},{"key":"10.1016\/j.jtha.2025.01.009_bib78","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/bjh.19414","article-title":"Cancer-associated venous thrombosis in adults (second edition): a British Society for Haematology Guideline","volume":"205","author":"Alikhan","year":"2024","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2025.01.009_bib79","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1182\/bloodadvances.2020003442","article-title":"American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer","volume":"5","author":"Lyman","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2025.01.009_bib80","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1055\/s-0041-1740254","article-title":"Effectiveness and safety of apixaban versus warfarin in venous thromboembolism patients with chronic kidney disease","volume":"122","author":"Cohen","year":"2022","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.01.009_bib81","first-page":"2015","article-title":"A\u00a0systematic review of the efficacy and safety of anticoagulants in advanced chronic kidney disease","volume":"35","author":"Parker","year":"2022","journal-title":"J\u00a0Nephrol"},{"key":"10.1016\/j.jtha.2025.01.009_bib82","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/CIRCULATIONAHA.116.022361","article-title":"Impact of renal function on outcomes with edoxaban in the ENGAGE AF-TIMI 48 trial","volume":"134","author":"Bohula","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2025.01.009_bib83","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.amjmed.2016.12.033","article-title":"Oral anticoagulant use after bariatric surgery: a literature review and clinical guidance","volume":"130","author":"Martin","year":"2017","journal-title":"Am J Med"},{"key":"10.1016\/j.jtha.2025.01.009_bib84","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.soard.2021.12.023","article-title":"The APB study: apixaban pharmacokinetics in bariatric patients before to 1 year after vertical sleeve gastrectomy or Roux-en-Y gastric bypass","volume":"18","author":"teele","year":"2022","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.jtha.2025.01.009_bib85","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/bjh.19635","article-title":"BSH Committee. Guidelines on the investigation and management of antiphospholipid syndrome","volume":"205","author":"Arachchillage","year":"2024","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2025.01.009_bib86","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jacc.2022.10.008","article-title":"Direct oral anticoagulants vs vitamin K antagonists in patients with antiphospholipid syndromes: meta-analysis of randomized trials","volume":"81","author":"Khairani","year":"2023","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jtha.2025.01.009_bib87","article-title":"CAVA (Ultrasound-Accelerated Catheter-Directed Thrombolysis on Preventing Post-Thrombotic Syndrome) Trial: long-term follow-up results","volume":"10","author":"Notten","year":"2021","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jtha.2025.01.009_bib88","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.1016\/S2352-3026(15)00248-3","article-title":"Post-thrombotic syndrome after catheter-directed thrombolysis for deep vein thrombosis (CaVenT): 5-year follow-up results of an open-label, randomised controlled trial","volume":"3","author":"Haig","year":"2016","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jtha.2025.01.009_bib89","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1056\/NEJMoa1615066","article-title":"Pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis","volume":"377","author":"Vedantham","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2025.01.009_bib90","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1001\/jama.2014.5990","article-title":"Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis","volume":"311","author":"Chatterjee","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jtha.2025.01.009_bib91","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJMoa1302097","article-title":"Fibrinolysis for patients with intermediate-risk pulmonary embolism","volume":"370","author":"Meyer","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2025.01.009_bib92","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.amjcard.2012.09.027","article-title":"Moderate pulmonary embolism treated with thrombolysis (from the \u201cMOPETT\u201d Trial)","volume":"111","author":"Sharifi","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jtha.2025.01.009_bib93","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1001\/jama.2015.3780","article-title":"PREPIC2 Study Group. Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone on risk of recurrent pulmonary embolism: a randomized clinical trial","volume":"313","author":"Mismetti","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.jtha.2025.01.009_bib94","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.jacc.2017.07.775","article-title":"Inferior vena cava filters to prevent pulmonary embolism: systematic review and meta-analysis","volume":"70","author":"Bikdeli","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jtha.2025.01.009_bib95","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d3036","article-title":"Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants' data from seven trials","volume":"342","author":"Boutitie","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jtha.2025.01.009_bib96","doi-asserted-by":"crossref","first-page":"5595","DOI":"10.1182\/bloodadvances.2020002268","article-title":"Which patients are at high risk of recurrent venous thromboembolism (deep vein thrombosis and pulmonary embolism)?","volume":"4","author":"\u00c1inle","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2025.01.009_bib97","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1111\/jth.13336","article-title":"Subcommittees on Control of Anticoagulation, and Predictive and Diagnostic Variables in Thrombotic Disease. Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH","volume":"14","author":"Kearon","year":"2016","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.01.009_bib98","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0140-6736(03)14111-6","article-title":"Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study","volume":"362","author":"Baglin","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2025.01.009_bib99","first-page":"31","article-title":"Addendum to Guidelines on travel-related venous thrombosis","volume":"152","author":"Riat","year":"2010","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.jtha.2025.01.009_bib100","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1161\/CIR.0000000000000130","article-title":"Council on Clinical Cardiology, and Council on Cardiovascular and Stroke Nursing. The post-thrombotic syndrome: evidence-based prevention, diagnosis, and treatment strategies: a scientific statement from the American Heart Association","volume":"130","author":"Kahn","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2025.01.009_bib101","first-page":"423","article-title":"The clinical course of deep-vein thrombosis. Prospective long-term follow-up of 528 symptomatic patients","volume":"82","author":"Prandoni","year":"1997","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2025.01.009_bib102","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1182\/blood-2018-01-785956","article-title":"How I treat the postthrombotic syndrome","volume":"131","author":"Rabinovich","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.01.009_bib103","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01792-2016","article-title":"Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a contemporary view of the published literature","volume":"49","author":"Ende-Verhaar","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jtha.2025.01.009_bib104","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1002\/rth2.12404","article-title":"Essential aspects of the follow-up after acute pulmonary embolism: an illustrated review","volume":"4","author":"Boon","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.01.009_bib105","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.blre.2014.07.003","article-title":"The post-PE syndrome: a new concept for chronic complications of pulmonary embolism","volume":"28","author":"Klok","year":"2014","journal-title":"Blood Rev"},{"key":"10.1016\/j.jtha.2025.01.009_bib106","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02828-2020","article-title":"ERS statement on chronic thromboembolic pulmonary hypertension","volume":"57","author":"Delcroix","year":"2021","journal-title":"Eur Respir J"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625000522?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625000522?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T08:22:37Z","timestamp":1774254157000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783625000522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":104,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S1538783625000522"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2025.01.009","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Basics of diagnosis and treatment of venous thromboembolism","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2025.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}